Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 11:51 am Purchase |
2025-03-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
The Vanguard Group | 13,056,605 10.030% |
1,112,710 (+9.32%) |
Filing History |
| 2025-02-13 2:14 pm Purchase |
2024-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
Capital Research Global Investors | 6,968,513 5.400% |
6,968,513 (New Position) |
Filing History |
| 2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
FMR CORP | 14,755,604 11.484% |
1,490,226 (+11.23%) |
Filing History |
| 2024-11-08 10:34 am Sale |
2024-09-30 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
WELLINGTON MANAGEMENT CO LLP | 5,018,779 3.910% |
-2,234,128 (-30.80%) |
Filing History |
| 2024-08-12 09:40 am Purchase |
2024-08-09 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
FMR CORP | 13,265,378 10.484% |
2,922,981 (+28.26%) |
Filing History |
| 2024-07-05 10:24 am Sale |
2024-06-28 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BAILLIE GIFFORD & CO | 6,032,656 4.770% |
-934,441 (-13.41%) |
Filing History |
| 2024-02-13 4:59 pm Purchase |
2023-12-29 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
The Vanguard Group | 11,943,895 9.520% |
436,779 (+3.80%) |
Filing History |
| 2024-02-09 6:14 pm Sale |
2024-02-07 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
Capital World Investors | 16,398,889 13.100% |
-195,069 (-1.18%) |
Filing History |
| 2024-02-09 08:40 am Purchase |
2023-12-29 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
WELLINGTON MANAGEMENT CO LLP | 7,252,907 5.780% |
991,265 (+15.83%) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
FMR CORP | 10,342,397 8.239% |
-3,200,428 (-23.63%) |
Filing History |
| 2024-01-29 12:18 pm Sale |
2023-12-29 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BAILLIE GIFFORD & CO | 6,967,097 5.550% |
-2,440,774 (-25.94%) |
Filing History |
| 2024-01-26 5:25 pm Sale |
2023-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
8,546,557 6.800% |
-119,145 (-1.37%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
PRICE T ROWE ASSOCIATES INC | 4,074,144 3.300% |
-2,461,224 (-37.66%) |
Filing History |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
Capital World Investors | 16,593,958 13.500% |
3,777,181 (+29.47%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
The Vanguard Group | 11,507,116 9.350% |
804,345 (+7.52%) |
Filing History |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
FMR CORP | 13,542,825 11.005% |
-4,397,195 (-24.51%) |
Filing History |
| 2023-02-06 2:43 pm Sale |
2022-12-30 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
WELLINGTON MANAGEMENT CO LLP | 6,261,642 5.090% |
-578,179 (-8.45%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BLACKROCK INC BLK |
8,665,702 7.000% |
994,300 (+12.96%) |
Filing History |
| 2023-01-19 12:08 pm Sale |
2022-12-30 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
BAILLIE GIFFORD & CO | 9,407,871 7.650% |
-1,208,880 (-11.39%) |
Filing History |
| 2022-09-09 12:30 pm Purchase |
2022-09-09 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
Capital World Investors | 12,816,777 10.700% |
12,816,777 (New Position) |
Filing History |